1[1]Stella M, Cassano P, Bollero D, et al. Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience[J]. Dermatology, 2001, 203(1): 45-59.
2[2]Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal neerolysis by blockade of CD95 with human intravenous immunoglobulin[J]. Science, 1998, 282(5388): 490-493.
3Yeung CK, Lain LK, Chan HH. The timing of intravenous immunoglobulin therapy in Steven-Johnson Syndrome and toxic epidermal necrolysis [ J ]. Clin Exp Dermatol, 2005, 30 ( 5 ) :600-602.
4Fischer M, Hamm H, Werbelauer J, Sever drug-related skin reaction: toxic epidermal necrolysis caused by carbamazepine[J]. Klin Padiatr, 2004, 216(5) : 288-293.
5Campione E, Marulli Gc, Carrozzo AM, et al. High-dose intravenous immunoglobulin for severe drug reaction: efficacy in TEN [J]. Acta Derm Venereol, 2003, 83(6) : 430-432.
